MedTrace Logo

Safety Study That Compares Perlane to Perlane With Lidocaine (Perlane-L) While Correcting Wrinkles in the Area Around Your Nose

NCT00823069 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2010-11-30

Study results available
· View outcomes & findings →

Summary

Safety study that compares Perlane to Perlane with Lidocaine while correcting wrinkles in the area around your nose.

Conditions

  • Nasolabial Folds

Interventions

DEVICE

Perlane and Perlane-L

This is a split face design and each subject received both Perlane-L and Perlane. Treatments were blinded, randomized, and successive.

Sponsors & Collaborators

  • Q-Med Scandinavia, Inc.

    collaborator INDUSTRY

  • Medicis Global Service Corporation

    lead INDUSTRY

Principal Investigators

  • Mary Sanstead · Medicis Global Pharmaceutical

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-03-31
Completion
2009-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00823069 on ClinicalTrials.gov